Arthex Biotech receives EUR 1.2m from CDTI

We have advised Arthex Biotech, a Spain-based startup, which has received EUR 1.2m from the Innvierte program, which belongs to the Centro para el Desarrollo Tecnológico e Industrial (CDTI).  

Arthex Biotech, based in Paterna, Valencia, is engaged in the development of antisense RNA treatments against genetic diseases.